Complex Generics: Pre-Competitive Research Collaborations To Get US FDA Funding Boost

 
• By Derrick Gingery

Center for Research on Complex Generics will be similar to the Critical Path Institute; training sessions for industry could begin in January.

Complexity (Michael D Brown/Shutterstock.com)
The FDA is funding an academic center intended to promote pre-competitive industry collaboration on complex generic development. • Source: Shutterstock

The US Food and Drug Administration is hoping an academic-run group can boost industry’s involvement in complex generic drug research.

A five-year, $5m grant to the University of Maryland and University of Michigan will establish the 

More from Generics

More from Biosimilars & Generics